Revelation Biosciences to Host Fireside Chat at 37th Annual Roth Conference

About this update from Revelation Biosciences, Inc.

SAN DIEGO, March 13, 2025 --( BUSINESS WIRE )-- Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing inflammation to optimize health, announced today that James Rolke Revelation’s Chief Executive Officer, will participate in a fireside chat at the 37 th Annual Roth Conference on Tuesday, March 18, 2025 at 10:00 a.m. PT in Dana Point, CA. The fireside chat will be webcast live here and available on our Investors section of Revelation Biosciences website, www.RevBiosciences.com , after the meeting. Investors who wish to schedule a meeting with Revelation’s management during the conference should contact their Roth representative. About Revelation Biosciences, Inc. Revelation Biosciences, Inc. is a clinical stage life sciences company focused on harnessing the power of trained immunity for the prevention and treatment of disease using its proprietary formulation Gemini . Revelation has multiple ongoing programs to evaluate Gemini, including as a prevention for post-surgical infection, as a prevention for acute kidney injury, and for the treatment of chronic kidney disease. For more information on Revelation, please visit www.RevBiosciences.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20250313776522/en/ Contacts Company Contacts Mike Porter Investor Relations Porter LeVay & Rose Inc. Email: [email protected] Chester Zygmont, III Chief Financial Officer Revelation Biosciences Inc. Email: [email protected]

View stock analysis, news, and events for Revelation Biosciences, Inc.